Chitosan modification and pharmaceutical/biomedical applications. - Wikidata - awgldk - TriplyDB

Chitosan modification and pharmaceutical/biomedical applications.

Chitosan modification and pharmaceutical/biomedical applications.

http://www.wikidata.org/entity/Q34061817

about

Chitosan: A Promising Marine Polysaccharide for Biomedical Research Chitosanases from Family 46 of Glycoside Hydrolases: From Proteins to Phenotypes Biosafe nanoscale pharmaceutical adjuvant materials An Overview of the Medical Applications of Marine Skeletal Matrix Proteins An Overview of the Protective Effects of Chitosan and Acetylated Chitosan Oligosaccharides against Neuronal Disorders.Biocompatibility of chitosan carriers with application in drug delivery.Glycoprotein IIb/IIIa and P2Y12 induction by oligochitosan accelerates platelet aggregation.Antiinflammatory and antinociceptive effects in mice of a sulfated polysaccharide fraction extracted from the marine red algae Gracilaria caudata.Shear-thinning nanocomposite hydrogels for the treatment of hemorrhage.One-step colloidal synthesis of biocompatible water-soluble ZnS quantum dot/chitosan nanoconjugates.Recent advancement of chitosan-based nanoparticles for oral controlled delivery of insulin and other therapeutic agents.GNPs-CS/KGM as hemostatic first aid wound dressing with antibiotic effect: in vitro and in vivo study Antinociceptive and anti-inflammatory activity from algae of the genus Caulerpa.Recent modifications of chitosan for adsorption applications: a critical and systematic review.Acetylated chitosan oligosaccharides act as antagonists against glutamate-induced PC12 cell death via Bcl-2/Bax signal pathway.The potential of chitosan and its derivatives in prevention and treatment of age-related diseases.Mycelial Mattress from a Sporangia Formation-Delayed Mutant of Rhizopus stolonifer as Wound Healing-Enhancing Biomaterial.Low-molecular-weight chitosan scavenges methylglyoxal and N (ε)-(carboxyethyl)lysine, the major factors contributing to the pathogenesis of nephropathy.Immunostimulative Activity of Low Molecular Weight Chitosans in RAW264.7 Macrophages.Antinociceptive and anti-inflammatory activities of crude methanolic extract of red alga Bryothamnion triquetrum.Enhanced hemostatic performance of tranexamic acid-loaded chitosan/alginate composite microparticles Dense chitosan surgical membranes produced by a coincident compression-dehydration process.Chondroitin sulfate, hyaluronic acid and chitin/chitosan production using marine waste sources: characteristics, applications and eco-friendly processes: a review.Nitric oxide-releasing chitosan oligosaccharides as antibacterial agents.A proteomic view to characterize the effect of chitosan nanoparticle to hepatic cells: is chitosan nanoparticle an enhancer of PI3K/AKT1/mTOR pathway?Biomedical exploitation of chitin and chitosan via mechano-chemical disassembly, electrospinning, dissolution in imidazolium ionic liquids, and supercritical drying.Green synthesis approach: extraction of chitosan from fungus mycelia.Intranasal formulations: promising strategy to deliver vaccines.Nutraceuticals in lipid-lowering treatment: a narrative review on the role of chitosan.Proliferation of keratinocytes induced by adipose-derived stem cells on a chitosan scaffold and its role in wound healing, a review.Aqueous and methanolic extracts of Caulerpa mexicana suppress cell migration and ear edema induced by inflammatory agents.Current and potential uses of bioactive molecules from marine processing waste.Stimulatory Effect of Balanced Deep-Sea Water Containing Chitosan Oligosaccharides on Glucose Uptake in C2C12 Myotubes.Positive charge of chitosan retards blood coagulation on chitosan films.Effect of phytic acid, ethylenediaminetetraacetic acid, and chitosan solutions on microhardness of the human radicular dentin.S-Nitrosothiol-modified nitric oxide-releasing chitosan oligosaccharides as antibacterial agents Preparation of Chitosan-Based Hemostatic Sponges by Supercritical Fluid Technology.Recent Advances in Nanocomposite Materials of Graphene Derivatives with Polysaccharides.Inactivation of heparin by cationically modified chitosan.The influence of 1-butanol and trisodium citrate ion on morphology and chemical properties of chitosan-based microcapsules during rigidification by alkali treatment.

P2860

Q26752958-6760FB01-E060-4AB8-9919-05360D1854E4 Q26777792-781FA638-EAE1-4DC4-BB07-2BF7D3DF1D86 Q26829798-7A571C32-289E-4727-A0B0-A5B93048A3A8 Q28074092-04F4C7D4-5070-4F23-87F2-F23590B39286 Q33612147-C70176B8-5E52-4A62-99AE-7BA37DB4E3A6 Q33649839-FA19704B-3A12-48B5-8DAB-E0FDCD2F34EF Q34176926-51CF010F-034E-4B90-A6F2-50E248A0A9E0 Q34351525-09FD05E2-1C20-45DB-A650-99EBF43F92C1 Q34419933-208D7EC7-A7E0-47F4-80F3-EEE542B074D7 Q34522277-41456805-1180-400B-824B-B189BC189C84 Q34733812-832CF44F-1770-4C36-BC7E-8F91EA2EA166 Q34846573-892D4176-DD82-426D-9B6F-FE61D0BE255A Q34874316-28BC1F43-1D7D-4B91-8559-8EDECD202F87 Q35015347-2ED131DA-3332-4E96-993E-E5A302D3CBE7 Q35228214-A25389DF-B664-4E1B-858A-2E330A89E134 Q35548877-DA0A2CDD-AFE1-442A-A85C-FBC929C31842 Q35746616-E633C86D-01BC-4D03-BC38-31901F36ABF7 Q35811824-9DC1641B-0F4E-419A-B937-88FFB3E927A3 Q36226743-13A13865-E980-4E8C-AC5A-36C67FC910E8 Q36329853-4E2AFCA9-D4C0-4E4B-A746-2C29B1E218C3 Q36411350-E5F7FD9E-950A-4990-98EB-D6C0FB423977 Q36756873-4D4FB851-B46E-430D-889E-7AA520F20454 Q36994144-03F4D2FC-BB6E-4BA3-B2B4-3A1D88CB8067 Q37469998-11FDCD57-8A17-49A8-B4F4-5F2081CD28BB Q37686640-0E9BC110-4B68-4C04-82A2-94CCA288D528 Q37963372-DACAEA7A-3E97-45A9-A05C-34D8F1E5F244 Q38053216-97AFDFB6-426C-4F05-A5EF-6C3450EF182B Q38223050-20D44B3F-02EC-44DA-B45F-A51149610053 Q38231113-4A714EA0-7C77-4F66-9976-576436A02FB3 Q38256174-1FE0841E-30C2-4BBD-9BAA-3FE3AB3D22FA Q38274136-9F62F75B-3392-4B02-8679-17955D3353F8 Q38579194-B265A529-3778-41FF-B718-0D6CC89541C7 Q38769086-F5EBF4C8-6F68-4D86-9902-1B7063523143 Q39671002-C1D90193-AE82-4B08-AEFB-57008090143E Q39728511-7B69C618-1F34-4F48-A5B2-D5382C390FD5 Q40952689-5F1521DA-4BF7-40E8-8C36-4428CE6F54E3 Q41912079-FE6BF34E-EE78-48CE-B762-36D4D8893CF4 Q42228541-35B3BCAA-6055-42E0-A40D-AAA92B0ADEAC Q42264131-647EA08E-79EF-43EA-9746-768953082741 Q43083216-D6A94D59-74C8-48D9-A9AA-B3A9179ABC08

P2860

Chitosan modification and pharmaceutical/biomedical applications.

http://www.wikidata.org/entity/Q34061817

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Chitosan modification and pharmaceutical/biomedical applications.

@ast

Chitosan modification and pharmaceutical/biomedical applications.

@en

Chitosan modification and pharmaceutical/biomedical applications.

@nl

type

label

Chitosan modification and pharmaceutical/biomedical applications.

@ast

Chitosan modification and pharmaceutical/biomedical applications.

@en

Chitosan modification and pharmaceutical/biomedical applications.

@nl

prefLabel

Chitosan modification and pharmaceutical/biomedical applications.

@ast

Chitosan modification and pharmaceutical/biomedical applications.

@en

Chitosan modification and pharmaceutical/biomedical applications.

@nl

P1433

Q34061817-A2CD9293-9C98-4870-B289-9A9E2DDE504A

P1476

Q34061817-941F53E0-CEF0-4B1D-925D-C696ECE30198

P2093

Q34061817-050644FD-940E-4F11-BD65-A8959BF5EE74

Q34061817-122678F9-1B46-4E82-BFCB-E4B20F65703B

Q34061817-6735C565-A2F4-46C5-8709-D94B0B325A0C

Q34061817-6EFE1FE7-F963-42C6-BF5C-40FEA50A4914

Q34061817-94538FCB-16C5-4BCE-A77B-36AF1FC03AE9

Q34061817-9FED2BBC-A045-4BF0-B99F-AB7B1619F288

Q34061817-A77A1CA7-7979-4980-9F05-4EE892D30547

P275

Q34061817-F85BEA88-C4B5-4C3C-B72F-0E76D2DD784F

P2860

Q34061817-0110C824-E950-4476-A2D8-0D340BC72C28

Q34061817-07534516-2C03-4533-8DBE-631C514E5B11

Q34061817-09726EE5-8568-4432-B16B-80971E4AF378

Q34061817-0D64436B-D19F-4F39-9685-5A1DE4A7ADCF

Q34061817-0DEAA58F-0D3A-4EB0-B0CC-77FE18206393

Q34061817-0E6B2296-C08F-4BCF-ACDC-0006CBB87E31

Q34061817-17F53CC7-EFB8-4771-935B-0BB8AE6EE1CA

Q34061817-18BA1F76-4C1A-4C5B-A5B1-A6FB574E2EC3

Q34061817-1DC84CF7-95DC-48F9-9351-165C111F4FFE

Q34061817-2276C04B-6FA9-4B3E-AA9C-AC7A6BB9BC60

P304

Q34061817-5E8387C3-32AC-40A2-8840-3C72972C6995

P31

Q34061817-1FB83756-41CE-4793-9553-177F5FD01834

Q34061817-78B8BFBF-4617-4E26-BAE4-196A1E945559

P356

Q34061817-B0926CEF-31F6-4AA8-8C2C-303C2D84D2B5

P433

Q34061817-082673BE-FC0E-493F-BEF4-F7FE65555D2C

P478

Q34061817-FA805E7A-1FEF-46CB-8C53-4D57DDB9A615

P577

Q34061817-B51D22E6-3239-439A-AA80-FA2F0D205B48

P5875

Q34061817-B86AA465-05B5-476C-A6DF-708900DAE9EE

P698

Q34061817-EBCA9176-15B2-4FAE-8CE2-87131A6C00D2

P921

Q34061817-4040AAC7-56E5-4A14-8F45-2115EEB33FDB

Q34061817-57F9A4A3-7294-438E-9287-E033C26E211A

Q34061817-FF5F47E1-451F-4035-A96A-6E1D2CA50CD0

P932

Q34061817-028F0E6A-B46D-4B6D-AB57-7B3458C8D6AB

P356

P1433

P1476

Chitosan modification and pharmaceutical/biomedical applications.

@en

P2093

Bo Li

http://www.w3.org/2001/XMLSchema#string

Jiali Zhang

http://www.w3.org/2001/XMLSchema#string

Ping Liu

http://www.w3.org/2001/XMLSchema#string

Qinyuan Cheng

http://www.w3.org/2001/XMLSchema#string

Talba Tahirou

http://www.w3.org/2001/XMLSchema#string

Wenshui Xia

http://www.w3.org/2001/XMLSchema#string

Wenxiu Gu

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

Chitin and chitosan: Properties and applications

Novel chitosanase from Streptomyces griseus HUT 6037 with transglycosylation activity.

Enzymic preparation of water-soluble chitosan and their antitumor activity.

Purification, characterization, and gene analysis of a chitosanase (ChoA) from Matsuebacter chitosanotabidus 3001.

Characterization and blood coagulation evaluation of the water-soluble chitooligosaccharides prepared by a facile fractionation method.

Receptor-mediated stimulatory effect of oligochitosan in macrophages.

Chemical preparation and structural characterization of a homogeneous series of chitin/chitosan oligomers.

Isolation, characterization and heterologous expression of a novel chitosanase from Janthinobacterium sp. strain 4239

New chitosan-degrading strains that produce chitosanases similar to ChoA of Mitsuaria chitosanitabida

Nonopsonic phagocytosis of zymosan and Mycobacterium kansasii by CR3 (CD11b/CD18) involves distinct molecular determinants and is or is not coupled with NADPH oxidase activation

P304

1962-1987

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/MD8071962

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2010-06-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45660698

http://www.w3.org/2001/XMLSchema#string

P698

20714418

http://www.w3.org/2001/XMLSchema#string

P921

Angliavandeniai

pharmaceutical preparation

macromolecular substances

P932

2920537

http://www.w3.org/2001/XMLSchema#string